Skip to main content

The paradox of improved antiretroviral therapy in HIV: potential for nutritional modulation?

  • Lisa J. Ware (a1) and S. A. Wootton (a1)

Chronic infection with HIV type 1 is associated with alterations in macronutrient metabolism, specifically elevated plasma lipids, glucose and reduced insulin sensitivity. These alterations are most severe in patients at the later stages of AIDS, indicating a relationship with disease progression. Recently, a metabolic syndrome, termed lipodystrophy, has been described in successfully-treated HIV patients in whom the altered macronutrient metabolism of HIV infection appears to be amplified markedly, with concurrent alterations in adipose tissue patterning. This syndrome presents a paradox, as before the development of highly-active antiretroviral therapy (HAART) the most severe perturbations in metabolism were observed in the sickest patients. Now, the patients that respond well to therapy are showing metabolic perturbations much greater than those seen before. The implications of this syndrome are that, whilst life expectancy may be increased by reducing viral load, there are concomitant increases in the risk of cardiovascular disease, diabetes and pancreatitis within this patient population. The aetiology of the syndrome remains unclear. In a collaborative trial with the Chelsea and Westminster Hospital in London we have used stable-isotope-labelled fatty acids to examine the hypothesis that treatment with HAART causes a delayed clearance of dietary lipid from the circulation, resulting in the retention of lipid within plasma and the downstream changes in insulin and glucose homeostasis. This hypothesis would indicate a role for low-fat diets, exercise and drugs that reduce plasma lipid or insulin resistance, in modulating the response to antiretroviral therapy in HIV infection.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The paradox of improved antiretroviral therapy in HIV: potential for nutritional modulation?
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      The paradox of improved antiretroviral therapy in HIV: potential for nutritional modulation?
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      The paradox of improved antiretroviral therapy in HIV: potential for nutritional modulation?
      Available formats
Corresponding author
*Corresponding Author: Lisa Ware, present address SHS International Ltd, 100 Wavertree Boulevard, Liverpool L7 9PT, UK, fax +44 (0)151 228 2650, email
Hide All
Batterham M, Garsia R & Greenop P (2000) Dietary intake, serum lipids, insulin resistance and body composition in the era of HAART 'Diet FRS Study'. AIDS 14, 18391843.
Bell SJ, Chavali S, Bistrian B, Connolly CA, Utsonomiya T & Forse RA (1996) Dietary fish oil and cytokine production during HIV infection. Journal of Parenteral and Enteral Nutrition 20, 4349.
Brinkman K, Hofstede H, Burger D, Smeitinik J & Koopmans P (1998) Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12, 17351744.
Brinkman K, Smeitinik J, Romjin J & Reiss P (1999) Mitochondrial toxicity induced by nucleoside-analogue reverse transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354, 11121115.
Calder PC (1996) Effects of fatty acids and dietary lipids on cells of the immune system. Proceedings of the Nutrition Society 55, 127150.
Carr A & Cooper D (2000) Adverse effects of antiretroviral therapy. Lancet 356, 14231430.
Carr A, Samaras K, Chisholm D & Cooper D (1998) Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 352, 18811883.
Carr A, Samaras K, Thorisdottir A, Kauffman G, Chisholm D & Cooper D (1999) Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353, 20932099.
Christeff N, Lortholary O, Casassus P, Thobie N, Dalle M, Veyssier P, Guillevin L & Nunez E (1995) Serum lipid concentration with reference to the clinical and immunological status of HIV infected men. Annales de Médecine Interne 146, 490495.
Cloyd MW (1991) Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Virology 181, 500511.
Constans J, Pellegrin J & Peuchant E (1994) Plasma lipids in HIV-infected patients: a prospective study in 95 patients. European Journal of Clinical Investigation 24, 416420.
Constans J, Peuchant E & Pellegrin J (1995) Fatty acids and plasma antioxidants in HIV-positive patients: correlation with nutritional and immunological status. Clinical Biochemistry 28, 421426.
Endres S (1993) Messengers and mediators: interactions among lipids, eicosanoids and cytokines. American Journal of Clinical Nutrition 57, 78958005.
Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JMW, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaeffer EJ, Wolff SM & Dinarello CA (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumour necrosis factor by mononuclear cells. New England Journal of Medicine 320, 265271.
Feingold K, Adi S, Staprins I, Moser A, Neese R, Verdier JA, Doerrler W & Grunfeld C (1990) Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. American Journal of Physiology 259, E177E184.
Fernandez-Miranda C, Pulido F & Carrillo JL (1998) Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers. Clinica Chimica Acta 274, 6370.
Frayn K, Shadid S, Hamlani R, Humphreys S, Clark ML, Fielding BA, Boland O & Coppack SW (1994) Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. American Journal of Physiology 266, E308E317.
Gazzard B (editor) (1999) Weight loss and diarrhoea. In Chelsea and Westminster Hospital AIDS Care Handbook, pp. 201214. London: Mediscript Ltd.
Gomez-Sirvent JL, Alonso-Socas MM, Santolaria-Fernandez FJ, Gonzalez-Reimers CE, Rodriguez-Moreno F & Essardas-Daryanani H (1994) Prognostic value of triglyceride levels in early HIV infection. AIDS 8, 17401741.
Grunfeld C & Feingold K (1991) The metabolic effects of tumour necrosis factor and other cytokines. Biotherapy 3, 143158.
Grunfeld C & Feingold K (1992) Metabolic disturbances and wasting in AIDS. New England Journal of Medicine 327, 329335.
Grunfeld C, Kotler D & Shigenaga (1991) Circulating IFN-alpha and hypertriglyceridaemia in AIDS. American Journal of Medicine 90, 154162.
Grunfeld C, Pang M, Doerrler W, Shigenaga J, Jensen P & Feingold K (1992) Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Journal of Clinical Endocrinology and Metabolism 74, 10451052.
Hellerstein M, Grunfield C, Wu K, Christiansen M, Kaempfer S, Kletke C & Shackleton C (1993) Increased de novo hepatic lipogenesis in HIV infection. Journal of Clinical Endocrinology and Metabolism 76, 559565.
Hommes M, Romjin J, Endert E & Sauerwein H (1991) Resting energy expenditure and substrate oxidation in HIV-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. American Journal of Clinical Nutrition 54, 311315.
Jahoor F, Jackson AA, Gazzard B, Phillips G, Sharpstone D, Frazer M & Heird W (1999) Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate. American Journal of Physiology 276, E205E211.
Klein A, Bruser B, Bast M & Rachlis A (1992) Progress of HIV infection and changes in the lipid membrane structure of CD4+ cells. AIDS 6, 332333.
Koppel K (2000) Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection. International Journal of STD and AIDS 11, 451455.
Kotler D & Heymsfield S (1998) HIV Infection: a model chronic illness for studying wasting diseases. American Journal of Clinical Nutrition 68, 519520.
Mallal S, John M, Moore C, James I & McKinnon E (2000) Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 14, 13091316.
Mercie P (2000) Atherogen lipid profile in HIV-1 infected patients with lipodystrophy syndrome. European Journal of Internal Medicine 11, 257263.
Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello C & Gorbach SL (1991) Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. Journal of Nutrition 121, 547555.
Meyer L, Rabaud C, Ziegler O, May T & Drouin P (1998) Protease inhibitors, diabetes mellitus and blood lipids. Diabetes Metabolism 24, 547549.
Mulligan K, Grunfeld C, Hellerstein M, Neese R & Schambelan M (1993) Anabolic effects of recombinant human growth hormone in patients with wasting associated with HIV infection. Journal of Clinical Endocrinology and Metabolism 77, 956962.
Noor MA, Lo JC, Mulligan K, Shwarz JM, Halvorsen RA, Schambelan M & Grunfeld C (2001) Absent HIV infection, Indinavir causes insulin resistance. AIDS 15, 1118.
Nunez E & Christeff N (1994) Steroid hormone, cytokine, lipid and metabolic disturbances in HIV infection. Baillieres Clinical Endocrinology and Metabolism 8, 803824.
Pacht ER, Diaz P, Clanton T, Hart J & Gaadek JE (1997) Serum vitamin E decreases in HIV-seropositive subjects over time. Journal of Laboratory and Clinical Medicine 130, 293296.
Purnell J, Zambon A, Knopp R et al. (1999) Effect of Ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS 14, 5157.
Roubenouff R, Weiss L, McDermott A, Heflin T, Cloutier G, Wood M & Gorbach S (1999) A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 13, 13731375.
Sappey C, Leclercq P, Coudray C, Faure P, Micoud M & Favier A (1994) Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clinica Chimica Acta 230, 3542.
Silva M, Skolnik PR, Gorbach SL, Spiegelman D, Wilson IB, Fernandez-Di Franco MG & Knox TA (1998) The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 12, 16451651.
Sullivan AK, Feher MD, Nelson MR & Gazzard BG (1998) Marked hypertriglyceridaemia associated with ritonavir therapy. AIDS 12, 13931395.
Taskinen MR (1995) Insulin resistance and lipoprotein metabolism. Current Opinion in Lipidology 6, 153160.
Terrence Higgins Trust (2001) Terrence Higgins Trust factsheet.
Tikkanen MJ, Ojala J & Helve E (1992) Long term use of Lovastatin in different types of hyperlipidaemia. Atherosclerosis 97, S27S32.
Turcotte L, Srivastava A & Chiasson J (1997) Fasting increases plasma membrane fatty acid-binding protein in red skeletal muscle. Molecular and Cellular Biochemistry 166, 153158.
Ware LJ, Morlese J, Burdge G, Jackson AA, Gazzard B & Wooton SA (2000) Differences in postprandial lipid metabolism in patients with PI-associated and NRTI-associated lipodystrophy. Antiviral Therapy 5, Suppl. 5, 13.
Ware LJ, Morlese J, Gazzard B, Burdge GC, Jackson AA & Wooton SA (2001) Highly active anti-retroviral therapy (HAART) in HIV-1 positive men increases the retention time of dietary lipid within the circulation. Proceedings of the Nutrition Society 60, 31A.
Xiang S, Cianflone K, Kalant D & Sniderman A (1999) Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. Journal of Lipid Research 40, 16551662.
Yarasheski K, Tebas P & Stanerson B (2001) Resistance exercise training reduces hypertriglyceridaemia in HIV-infected men treated with antiviral therapy. Journal of Applied Physiology 90, 133138.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 0
Total number of PDF views: 49 *
Loading metrics...

Abstract views

Total abstract views: 72 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 18th November 2017. This data will be updated every 24 hours.